Sunbird Bio is pioneering advancements in blood-based diagnostics, particularly for neurological disorders such as Alzheimer's and Parkinson's diseases. The company has developed the APEX technology platform, which allows for the direct detection and differentiation of specific proteins that aggregate in the brain, signaling the presence of these diseases. This innovative approach enables clinicians to obtain critical diagnostic information through a simple blood draw, addressing the significant challenges associated with current diagnostic methods, which are often invasive, expensive, and unreliable. The APEX platform has shown a high correlation with traditional PET imaging, making it a promising alternative for early and accurate diagnosis, which is crucial given the increasing availability of treatments for these conditions.

In addition to APEX, Sunbird Bio is also advancing the Glympse platform, which focuses on measuring and analyzing protease activity in the blood. This technology has the potential to provide insights into various diseases, including early-stage cancers, by detecting changes in protease activity that occur as diseases progress. Both APEX and Glympse aim to transform the standard of care by offering non-invasive, reliable diagnostic tests that can enhance patient monitoring and support drug development. By leveraging these technologies, Sunbird Bio seeks to empower healthcare providers with actionable information that can lead to improved patient outcomes and more effective treatment strategies.

United States

Sunbird Bio is a leader in protein-based diagnostic tests, becoming the first company to overcome the challenge of accurately detecting and differentiating the specific proteins that aggregate, and therefore signal the presence of Alzheimer’s disease, with a simple blood draw. We are addressing the tremendous, growing need for more reliable and sensitive diagnostic tests to accelerate drug development and enhance patient care.

Our pipeline of innovative, non-invasive technologies, such as our APEX technology, will empower researchers and clinicians with unparalleled insights not available from current tests. 

Sunbird Bio

Company Details